The University of Texas MD Anderson Cancer Center, located in Houston, Texas, is one of the world's leading cancer research and treatment institutions, founded in 1941. It is part of the University of Texas System and is recognized for its comprehensive cancer care, ranking consistently among the top cancer hospitals in the United States according to U.S. News & World Report. MD Anderson is known for its innovative research programs, including the development of targeted therapies and immunotherapies, with notable figures such as Dr. James Allison, who won the Nobel Prize in Physiology or Medicine in 2018 for his work on cancer immunotherapy. The center also hosts the annual "Moon Shots Program," launched in 2012, aimed at accelerating the development of new therapies for various types of cancer. With over 22,000 employees and a patient population exceeding 140,000 annually, MD Anderson is dedicated to cancer prevention, research, and education.